NOS3 and breast cancer: In accordance with our findings, previous studies have shown that NOS3 and AGTR1 are related to the chemoresistance of cancer [36–38]: NOS3 is related to oxaliplatin resistance in colorectal cancer cells [36], and AGTR1 is a marker of the drug resistance of breast cancer [37, 38].